Dysregulation of PRMT1 activity and expression is significantly associated with the pathogenesis of various immune‐mediated diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), asthma, and chronic graft‐versus‐host disease (cGVHD). The gene discussed is PRMT1; the disease is asthma.